We are live on
!
Find out more
TDC
Thompson Davis & Co Portfolio holdings
AUM
$150M
1-Year Est. Return
32.35%
This Fund
S&P 500
This Quarter
Est. Return
+11.83%
1 Year Est. Return
+32.35%
3 Year Est. Return
+199.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$42.2M
AUM Growth
-$14.3M
(-25%)
Cap. Flow
-$17.4M
Cap. Flow
% of AUM
-41.13%
Top 10 Holdings %
Top 10 Hldgs %
21.94%
Holding
1,277
New
146
Increased
131
Reduced
218
Closed
593
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Small-Cap Value ETF
VBR
|
+$601K |
| 2 |
Kinsale Capital Group
KNSL
|
+$335K |
| 3 |
Pixelworks
PXLW
|
+$273K |
| 4 |
General Motors
GM
|
+$255K |
| 5 |
MITL
Mitel Networks Corporation
MITL
|
+$250K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$623K |
| 2 |
Intel
INTC
|
+$608K |
| 3 |
Bank of America
BAC
|
+$558K |
| 4 |
Apple
AAPL
|
+$527K |
| 5 |
FDC
First Data Corporation
FDC
|
+$384K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.91% |
| 2 | Financials | 9.93% |
| 3 | Healthcare | 9.91% |
| 4 | Industrials | 9.33% |
| 5 | Consumer Discretionary | 7.9% |
Similar funds
PAYA
PCMNC
LA
MPW
GWA
GA
RPA
E
Thompson Davis & Co's Q4 2017 Portfolio in Review
As of Q4 2017, Thompson Davis & Co held 1,277 positions worth $42.2M, down 25% from $56.5M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Thompson Davis & Co withdrew a net $17.4M in Q4 2017, closing 593 positions and reducing 218 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $365K position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Thompson Davis & Co opened a new position in General Motors worth $241K.
- Thompson Davis & Co's largest Q4 2017 buy was General Motors: 5,878 shares worth $241K.
- Thompson Davis & Co added most to Vanguard Small-Cap Value ETF in Q4 2017, an estimated $601K increase.
- Thompson Davis & Co's biggest Q4 2017 reduction was JPMorgan Chase, cutting an estimated $623K.
- Thompson Davis & Co fully exited Antares Pharma, Inc. in Q4 2017, selling an estimated $365K.
- Thompson Davis & Co's ten largest holdings make up 22% of its $42.2M portfolio in Q4 2017.
- Thompson Davis & Co opened 146 new positions and closed 593 in Q4 2017.
- Thompson Davis & Co's portfolio value fell 25% quarter-over-quarter to $42.2M.
Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.